Estimates Revisions BioRestorative Therapies, Inc.
Stocks
BRTX
US0906556065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4000 USD | +3.73% |
|
+1.52% | -65.96% |
| 06-25 | BioRestorative Therapies Completes Manufacturing for BRTX-100 Phase 2 Clinical Trial | CI |
| 06-15 | BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- BRTX Stock
- Consensus BioRestorative Therapies, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
